Different Sensitivity of CD30 + Cell Lines to Ber-H2/Saporin-S6 Immunotoxin

References

• Barbieri L., Battelli M. G., Stirpe F. Ribosome-inactivating proteins from plants. Biochim. Biophys. Acta 1993; 1154: 237–282
   PubMed Web of Science ®Google Scholar
• Barbieri L., Stoppa C., Bolognesi A. Large scale chromatographic purification of ribosome-inactivating proteins. J. Chromatogr. 1987; 408: 235–243
   Web of Science ®Google Scholar
• Battelli M. G., Polito L., Bolognesi A., Lafleur L., Fradet Y., Stirpe F. Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell line. Int. J. Cancer 1996; 65: 485–490
   PubMed Web of Science ®Google Scholar
• Bolognesi A., Tazzari P. L., Legname G., Olivieri F., Modena D., Conte R., Stirpe F. Anti-CD30 immunotoxins with native and recombinant dianthin 30. Cancer Immunol. Immunother. 1995; 40: 109–114
   PubMed Web of Science ®Google Scholar
• Casellas P., Dussosoy D., Falasca A. I., Barbieri L., Bolognesi A., Cenini P., Stirpe F. Trichokirin, a ribosome-inactivating protein from the seeds of Trichosanthes kirilowii Maximowicz. Purification, partial characterization and use for preparation of immunotoxins. Eur. J. Biochem. 1988; 176: 181–188
   Google Scholar
• Duke-Cohan J. S., Morimoto C., Schlossman S. F. Depletion of the helper/inducer (memory) T cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD29. Transplantation 1993; 56: 1188–1196
   Google Scholar
• Endo Y. Mechanisms of action of ricin and related toxins on the inactivation of ribosomes. Immunotoxins, A.E. Frankel. Kluwier Academic Publishers, Boston 1988; 75–89
   Google Scholar
• Engert A., Brown A., Thorpe P. Resistance of myeloid leukaemia cell lines to ricin A-chain immunotoxins. Leukaemia Res. 1991; 15: 1079–1089
   PubMed Web of Science ®Google Scholar
• Falini B., Bolognesi A., Flenghi L., Tazzari P. L., Broe M. K., Stein H., Dürkop H., Aversa F., Corneli P., Pizzolo G., Barbabietola G., Sabattini E., Pileri S., Martelli M. F., Stirpe F. Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin. Lancet 1992a; 339: 1195–1196
   PubMed Web of Science ®Google Scholar
• Falini B., Flenghi L., Fedeli L., Broe M. K., Bonino C., Stein K., Dürkop H., Bigerna B., Barbabietola G., Venturi S., Aversa F., Pizzolo G., Bartoli A., Pileri S., Sabattini E., Palumbo R., Martelli F. In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 (CD30): immunohistological evidence. Brit. J. Haematol. 1992b; 82: 38–45
   PubMed Web of Science ®Google Scholar
• Falini B., Pileri S., Pizzolo G., Diirkop H., Flenghi L., Stirpe F., Martelli M. F., Stein H. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85: 1–14
   PubMed Web of Science ®Google Scholar
• Fraker P. J., Speck J.C., Jr. Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetra-chloro-3a,6a-diphenylglycoluril. Biochem. Byophys. Res. Comm. 1978; 80: 849–857
   PubMed Web of Science ®Google Scholar
• Glantz S. A. Primer of Biostatistics. Mc Graw-Hill, New York 1987
   Google Scholar
• Goldmacher V. S., Blättler W. A., Lambert J. M., McIntyre G., Stewart J. Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber. Mol. Pharmacol. 1989; 36: 818–822
   PubMed Web of Science ®Google Scholar
• Jansen F. K., Jansen A., Derocq J. M., Carrière D., Carayon P., Veas F., Jaffrézou J. P. Golgi vacuolization and immunotoxin enhancement by monensin and perhexiline depend on a serum protein. Implication for intracellular trafficking. J. Biol. Chem. 1992; 267: 12577–12582
   PubMed Web of Science ®Google Scholar
• Lambert J. M., Senter P. D., Yau-Young A., Blättler W. A., Goldmacher V. S. Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to ribosome-inactivating proteins gelonin and pokeweed antiviral proteins. J. Biol. Chem. 1985; 260: 12035–12041
   PubMed Web of Science ®Google Scholar
• Olsnes S., Sandvig K. How protein toxins enter and kill cells. Immunotoxins, A. E. Frankel. Kluwier Academic Publishers, Boston 1988; 39–73
   Google Scholar
• Parente A., De Luca P., Bolognesi A., Barbieri L., Battelli M. G., Abbondanza A., Sande M. J. W., Siniscalco Gigliano G., Tazzari P. L., Stirpe F. Purification and partial characterization of single-chain ribosome-inactivating proteins from the seeds of Phytolacca dioica L. Biochim. Biophys. Acta 1993; 1216: 43–49
   PubMed Web of Science ®Google Scholar
• Porro G., Lento P., Marcucci F., Gromo G., Modena D. Different cytotoxic activity and intracellular fate of an anti-CD5-momordin immunotoxin in normal compared to tumor cells. Cancer Immunol. Immunother. 1995; 40: 213–218
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S. Cytotoxic conjugates. R. G. Landes, Austin 1993
   Google Scholar
• Ramakrishnan S., Houston L. L. Inhibition of human acute lymphoblastic leukemia cells by immunotoxins: potentiation by chloroquine. Science 1984; 223: 58–61
   PubMed Web of Science ®Google Scholar
• Schwarting R., Gerdes J., Diirkop H., Falini B., Pileri S., Stein H. Ber-H2: a new anti K-l (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989; 74: 1678–1689
   PubMed Web of Science ®Google Scholar
• Stirpe F., Gasperi-Campani A., Barbieri L., Falasca A., Abbondanza A., Stevens W. A. Ribosome-inactivating proteins from the seeds of Saponaria officinalis L (soapwort), of Agrostemma githago L (corn cockle) and Asparagus officinalis L, and from the latex of Hura crepitans L (sandbox tree). Biochem. J. 1983; 216: 617–625
   PubMed Web of Science ®Google Scholar
• Tazzari P. L., Bolognesi A., De Totero D., Falini B., Lemoli R. M., Soria M. R., Pileri S., Gobbi M., Stein H., Flenghi L., Martelli M. F., Stirpe F. Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation. Brit. J. Haematol. 1992; 81: 203–211
   PubMed Web of Science ®Google Scholar
• Van Horssen P. J., Van Oosterhout V. J. M., De Witte T., Pre-ijers F. W. M. B. Cytotoxic potency of CD22-ricin A depends on intracellular routing rather than on the number of internalized molecules. Scand. J. Immunol. 1995; 41: 563–569
   PubMed Web of Science ®Google Scholar
• Yazdi P. T., Wenning L. A., Murphy R. M. Influence of cellular trafficking on protein synthesis inhibition of immunotoxins directed against the transferrin receptor. Cancer Res. 1995; 55: 3763–3771
   PubMed Web of Science ®Google Scholar